Based on the established oncogenic role of SRC in general cancer development and in particular in CRC and on the described analysis results of the FCVPPv2, the identified SRCV177M variant was considered to bear pathogenic potential leading to its prioritization for functional validation. The gene discussed is SRC; the disease is colorectal carcinoma.